NLM Digital Collections

Search

Start Over Subjects Prescription Drugs -- economics ✖Remove constraint Subjects: Prescription Drugs -- economics

47. One percent of drugs with Medicaid reimbursement were not FDA-approved

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, May 2019
Subject(s):
Drug Approval
Insurance, Health, Reimbursement -- economics
Insurance, Health, Reimbursement -- statistics & numerical data
Medicaid -- economics
Medicaid -- statistics & numerical data
Economics, Pharmaceutical
Fraud -- prevention & control
Prescription Drugs -- economics
Humans
United States
United States. Food and Drug Administration.

48. Rebates for brand-name drugs in Part D substantially reduced the growth in spending from 2011 to 2015

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, September 2019
Subject(s):
Drug Costs -- statistics & numerical data
Drug Costs -- trends
Insurance, Health, Reimbursement -- statistics & numerical data
Insurance, Health, Reimbursement -- trends
Medicare Part D -- economics
Medicare Part D -- statistics & numerical data
Medicare Part D -- trends
Economics, Pharmaceutical -- statistics & numerical data
Economics, Pharmaceutical -- trends
Forecasting
Prescription Drugs -- economics
Humans
United States

49. Utilization and spending trends in Medicaid outpatient prescription drugs

Author(s):
Young, Katherine, author
Publication:
[San Francisco, California] : Henry J. Kaiser Family Foundation, February 2019
Subject(s):
Drug Utilization -- economics
Drug Utilization -- trends
Health Expenditures -- trends
Medicaid -- economics
Medicaid -- trends
Prescription Drugs -- economics
Drugs, Generic -- economics
Forecasting
Humans
United States